Many international studies documented a systematic undertreatment of cardiovascular risk factors in diabetic women: the results of the DIANA study [46] indicated that men with diabetes were significantly more likely to receive any treatment for the major CVD risk factors, including oral hypoglycemic agents, ACE inhibitors, and calcium channel blockers for CHD, than women. Here, ACE is linked to diabetes mellitus.